As one expert told NutraIngredients in December 2025: Its really a choose-your-own-adventure
India is projected to show the highest regional CAGR at 8.4% during the forecast period, driven by the growing prevalence of diabetes, increasing healthcare access, and expanding awareness about GLP-1 therapies in the region
In poultry, it can significantly improve the growth of broilers and the egg-laying performance of layers, increase feed conversion efficiency, and reduce mortality
KPV (a tripeptide derived from alpha-MSH) is the distinguishing element of Klow compared to Glow it provides powerful anti-inflammatory action
Weight loss is never easy, but it shouldnt be impossible
Study: Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA